MPX-004
MPX-004 is a potent GluN2A antagonist. MPX-004 inhibits GluN2A-containing NMDA receptors expressed in HEK cells with an IC50 of 79 nM. MPX-004 has no inhibitory effect on GluN2B or GluN2D receptor-mediated responses. MPX-004 has the potential for neuropsychiatric and developmental disorders research[1].
Product Specifications
CAS Number
[1688684-07-2]
UNSPSC
12352005
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/mpx-004.html
Purity
99.58
Solubility
10 mM in DMSO
Smiles
O=C(C1=NC=C(CNS(=O)(C2=CC=C(C(Cl)=C2)F)=O)N=C1)NCC3=CN=C(C)S3
Molecular Formula
C17H15ClFN5O3S2
Molecular Weight
455.91
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
5-HT1 Receptor; NMDA Receptor
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PGR, CT (PGR, NR3C3, Progesterone receptor, Nuclear receptor subfamily 3 group C member 3) (MaxLight 550) discontinued
Alpha-Fetoprotein (AFP, HPAFP, Alpha-1-Fetoprotein, Alpha-Fetoglobulin) (FITC)
Alpha-Fetoprotein (AFP, HPAFP, Alpha-1-Fetoprotein, Alpha-Fetoglobulin) (FITC)
